Free shipping on all orders over $ 500

AZ 960

Cat. No. M1660
AZ 960 Structure
Synonym:

AZ960

Size Price Availability Quantity
Free Sample (0.5-1 mg)  USD 0 In stock
10mM*1mL in DMSO USD 100  USD100 In stock
2mg USD 80  USD80 In stock
5mg USD 130  USD130 In stock
10mg USD 210  USD210 In stock
50mg USD 600  USD600 In stock
Free Delivery on orders over USD 500 Bulk Inquiry?

Quality Control
Biological Activity

AZ960 is a novel and specific inhibitor of the JAK2 kinase with a Ki of 0.45nM in vitro.  AZ 960 effectively induced growth arrest and apoptosis of human T-cell lymphotropic virus type 1, HTLV-1-infected T cells (MT-1 and MT-2) in parallel with downregulation of the phosphorylated forms of Jak2 and Bcl-2 family proteins including Bcl-2 and Mcl-1.  Importantly, genetic inhibition of Bcl-xL by a small interfering RNA potentiated antiproliferative effects of AZ960 in MT-1 cells. Taken together, Jak2 is an attractive molecular target for treatment of ATL.

Product Citations
Customer Product Validations & Biological Datas
Source Bioorganic & Medicinal Chemistry (2016) . Figure 6. AZ960 was purchased from Abmole (Catalog No. M1660; Houston, TX)
Method Kinase assays
Cell Lines T. brucei, primary mouse left ventricle smooth muscle cells (vSMC), and rat pancreatic b cells (ins-1)
Concentrations 0.5 and 1 µM
Incubation Time 30 min
Results As shown in Figure 6, treatment of these cells with inhibitor concentrations ranging from 100 nM to 2 mM resulted in dosedependent inhibition of cell growth. The IC50 of AZ960 for mouse ventricular smooth muscle cells was determined to be 25 lM ± 3 and 10 lM ± 1 for rat pancreatic b cells.
Source Bioorganic & Medicinal Chemistry (2016) . Figure 5. AZ960 was purchased from Abmole (Catalog No. M1660; Houston, TX)
Method Kinase assays
Cell Lines
Concentrations 0.5 and 1 µM
Incubation Time 30 min
Results We calculated the Michaelis–Menten constant (Km) for TbERK8 to be 3.4 lM ± 0.12 (Fig. 5A). The inhibition constant (Ki) of AZ960 for TbERK8 was calculated to be 1.25 lM ± 0.35 (Fig. 5B).
Source Bioorganic & Medicinal Chemistry (2016) . Figure 4. AZ960 was purchased from Abmole (Catalog No. M1660; Houston, TX)
Method Kinase assays
Cell Lines
Concentrations 1 µM
Incubation Time 30 min
Results As shown in Figure 4, compounds that inhibited TbERK8 kinase activity to 20% or less included AZD5438, PF-03814735, Milciclib, and AZ960. Our studies suggest that SNS-032, NVP-BGT226, GSK2126458, Dinaciclib, and Torin 2 have anti-T. brucei activities with mechanisms that likely do not involve inhibition of TbERK8.
Source Bioorganic & Medicinal Chemistry (2016) . Figure 3. AZ960 was purchased from Abmole (Catalog No. M1660; Houston, TX)
Method Cell Titer-Glo Promega assay
Cell Lines T. brucei strain WT-221
Concentrations 80 nM to 1 µM
Incubation Time 48 h
Results The inhibitor activities ranged from 80 nM to 1 µM. Dinaciclib was the most potent inhibitor with an IC50 of 80 nM, but SNS-032, GSK2126458, and AZ960 were almost equally as potent with IC50 values of 120 nM, 111 nM, 120 nM, respectively. A representative dose–response curve for AZ960 is shown in Figure 3.
Source Bioorganic & Medicinal Chemistry (2016) . Figure 2. AZ960 was purchased from Abmole (Catalog No. M1660; Houston, TX)
Method luciferase-based phenotypic screen
Cell Lines T. brucei strain WT-221
Concentrations 1 µM
Incubation Time 48 h
Results A rescreen that tested the select hits demonstrated a dramatic decrease in the mean RLU values by about 2 log10 orders, confirming the antiparasitic activity of the compounds (Fig. 2).
Protocol
Cell Experiment
Cell lines SET-2 and TEL-JAK2 Ba/F3 cells
Preparation method Proliferation Assay
Cellular proliferation was evaluated using the fluorometric/colorimetric BIOSOURCE AlamarBlue Assay (Invitrogen) and read in the Spectra Max Gemini EM microplate reader (Molecular Devices, Sunnyvale, CA). SET-2 cells were plated at 20,000 cells/well, TEL-JAK2 Ba/F3 cells at 2000 cells/well, and all other TEL-JAKs at 5000 cells/well in 96-well plates. Cells were treated with compound 24 h after plating and grown for 72 h for SET-2 and 48 h for TEL-JAK Ba/F3 cells. Following the indicated growth period Alamar Blue (10 μl/well) was added, cells were incubated at 37 °C in 5% CO2 for 2 h, and fluorescence was measured at 545 (excitation) and 600 nm (emission). Data are normalized to percent of the control, and GI50 values (the concentration that causes 50% growth inhibition) were calculated using Xlfit4 version 4.2.2 for Microsoft Excel.
Concentrations 0~100 μM
Incubation time 72 h for SET-2 and 48 h for TEL-JAK Ba/F3 cells
Animal Experiment
Animal models
Formulation
Dosages
Administration
Conversion of different model animals based on BSA (Value based on data from FDA Draft Guidelines)
Species Mouse Rat Rabbit Guinea pig Hamster Dog
Weight (kg) 0.02 0.15 1.8 0.4 0.08 10
Body Surface Area (m2) 0.007 0.025 0.15 0.05 0.02 0.5
Km factor 3 6 12 8 5 20
Animal A (mg/kg) = Animal B (mg/kg) multiplied by  Animal B Km
Animal A Km

For example, to modify the dose of Compound A used for a mouse (20 mg/kg) to a dose based on the BSA for a rat, multiply 20 mg/kg by the Km factor for a mouse and then divide by the Km factor for a rat. This calculation results in a rat equivalent dose for Compound A of 10 mg/kg.

Chemical Information
Molecular Weight 354.36
Formula C18H16F2N6
CAS Number 905586-69-8
Purity 100.00%
Solubility DMSO 60 mg/mL
Storage at -20°C
References

[1] Ikezoe et al. Int J Cancer. Expression of p-JAK2 predicts clinical outcome and is a potential molecular target of acute myelogenous leukemia.

[2] Yang et al. Mol Cancer Ther. AZ960, a novel Jak2 inhibitor, induces growth arrest and apoptosis in adult T-cell leukemia cells.

[3] Gozgit JM, et al. J Biol Chem. Effects of the JAK2 inhibitor, AZ960, on Pim/BAD/BCL-xL survival signaling in the human JAK2 V617F cell line SET-2.

Related JAK Products
BMS-986202

BMS-986202 is a potent, selective, orally active Tyk2 inhibitor that binds to Tyk2 JH2 with an IC50 of 0.19 nM and a Ki of 0.02 nM. BMS-986202 is also a weak inhibitor of CYP2C19 with an IC50 of 14 μM. BMS-986202 can be used in IL-23-driven echinococcosis BMS-986202 can be used in studies of IL-23-driven echinococcosis, anti-CD40-induced colitis and spontaneous lupus.

GDC046

GDC046 (Compound 3) is a potent, selective, and orally bioavailable inhibitor of TYK2 with Ki of 4.8 nM, 83.8 nM, 27.6 nM and 253 nM for TYK2, JAK1, JAK2, and JAK3, respectively.

RO495

RO495 (CS-2667) is a potent inhibitor of Non-receptor tyrosine-protein kinase 2 (TYK2).

TG-89

TG-89 is a JAK inhibitor that inhibits JAK2, FLT3, RET and JAK3.

WYE-175765

WYE-175765 is a JAK3 and YopH inhibitor

  Catalog
Abmole Inhibitor Catalog




Keywords: AZ 960, AZ960 supplier, JAK, inhibitors

Contact Us

Products are for research use only. Not for human use. We do not sell to patients.
© Copyright 2010-2020 AbMole BioScience. All Rights Reserved.